• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
water filter
WATER FILTER FOR WATER PURIFIER
DUST BAG
Small dust filter
HUMIDIFIER FILTER
Oil fume adsorption filter

Divi’s, Gland, Fidelity enter race to buy Orchid Pharma

firstwordpharmaMarch 04, 2019

Tag: Divi’s , Fidelity , Orchid Pharma , Gland

  • The Economic Times reported that Divi's Laboratories, Divi’s Laboratories Gland Celsus Bio Chemicals and Fidelity Trading Corporation have shown preliminary interest in taking over Orchid Pharma.

  • Other bidders keen to acquire the bulk cephalosporin drugmaker include financial investors Everstone, Piramal Capital, AION Capital, ART Capital and Finquest Group.

  • The news comes after the Chennai bench of the National Company Law Tribunal (NCLT) knocked back a proposal by Ingen Capital to take over Orchid Pharma after it failed to bring in the requisite money.

Register as Visitor to CPhI China 2019!

Previous:Pharma Can BMS rebels scuttle its Celgene buy? Analysts do the math—and so far, the votes don't add up

Next:Eli Lilly to launch authorised Humalog generic in the US at 50-percent lower list price

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Divi’s, Gland, Fidelity enter race to buy Orchid Pharma | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Prostaglandin E2

Prostaglandin E2
Prostaglandin E1

Prostaglandin E1
(-)-corey lactone diol / Prostaglandins

(-)-corey lactone diol / Prostaglandins
Dinoprost Trometamol/Prostaglandin F2α Tromethamine

Dinoprost Trometamol/Prostaglandin F2α Tromethamine
Dinoprost Trometamol/ Prostaglandin F2a Tromethamine

Dinoprost Trometamol/ Prostaglandin F2a Tromethamine
(-)-corey lactone benzoate / Prostaglandins

(-)-corey lactone benzoate / Prostaglandins
Spironolactone prostaglandins

Spironolactone prostaglandins
Prostaglandin E1

Prostaglandin E1
PC-98T Egg yolk lecithin丨Prostaglandin injection

PC-98T Egg yolk lecithin丨Prostaglandin injection
(-)-corey lactone 4-phenylbenzoate / Prostaglandins

(-)-corey lactone 4-phenylbenzoate / Prostaglandins

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service